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What is the clinicopathological significance of psychotic 
symptoms in non-psychotic young people: Evidence from 4 
population-based studies 
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Abstract 
 
Background: Epidemiological research has shown that hallucinations and delusions, the 
classic symptoms of psychosis, are far more prevalent in the population than actual 
psychotic disorder. These symptoms are especially prevalent in childhood and 
adolescence. Longitudinal research has demonstrated that psychotic symptoms in 
adolescence increase risk for psychotic disorder in adulthood. There has been a lack of 
research, however, on the immediate clinicopathological significance of psychotic 
symptoms in adolescence. 
Aims: To investigate the relationship between psychotic symptoms and non-psychotic 
psychopathology in community samples of adolescents in terms of prevalence, co-
occurring disorders, comorbid (multiple) psychopathology, and variation across early 
versus middle adolescence. 
Method: Data from four population studies were used: 2 early adolescence studies (ages 
11 to 13 years) and two mid adolescence studies (ages 13 to 16 years). Studies 1 and 2 
involved school-based surveys of 2,242 11-to 16-year olds for psychotic symptoms and 
for emotional and behavioural symptoms of psychopathology. Studies 3 and 4 involved 
in-depth diagnostic interview assessments of psychotic symptoms and lifetime psychiatric 
disorders in community samples of 423 11-to 15-year olds. 
Results: Younger adolescents had a higher prevalence (21 to 23%) of psychotic 
symptoms than older adolescents (7%). In both age groups, the majority of adolescents 
who reported psychotic symptoms had at least one diagnosable non-psychotic psychiatric 
disorder, though associations with psychopathology increased with age: nearly 80% of 
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the mid-adolescence sample who reported psychotic symptoms had at least 1 diagnosis, 
compared to 57% of the early adolescence sample. Adolescents who reported psychotic 
symptoms were at particularly high risk of having multiple co-occurring diagnoses. 
Conclusions: Psychotic symptoms are important risk markers for a wide range of non-
psychotic psychopathology, in particular for severe psychopathology characterised by 
multiple co-occurring diagnoses. These symptoms should be carefully assessed in all 
patients. 
Declaration of interest: None 
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Introduction 
Hallucinations and delusions, the classic symptoms of psychosis, have recently been 
documented to occur at a much higher prevalence in the general population than 
clinically diagnosed psychotic disorder.1 A meta-analysis of prevalence studies of 
psychotic symptoms in young people demonstrated a median prevalence of 17% in 
children aged 9 to 12 years and 7.5% in adolescents aged 13 to 18 years.2 As the term 
suggests, psychotic symptoms have typically been considered to relate to psychotic 
disorder. Indeed, research has shown that members of the general population who report 
psychotic symptoms share a wide range of risk factors with schizophrenia patients3-8 (see 
9 for review) and young people who report psychotic symptoms have been found to be at 
increased risk of psychotic disorder in adulthood.10, 11 
 
More recently, several research groups have reported that individuals who report 
psychotic symptoms are also more likely to report symptoms of non-psychotic 
psychopathology, especially symptoms of depression.12-16 Yung et al., for example, 
reported that individuals who had a diagnosed depressive disorder endorsed an increased 
number of psychotic symptoms on the Community Assessment of Psychic Experiences 
(CAPE) questionnaire compared to controls.17 Bartels-Velthuis et al. found that young 
adolescents who disclosed psychotic symptoms were approximately 3 to 5 times more 
likely to score in the clinical psychopathology range on the parent-completed Child 
Behaviour Checklist.18 Community based studies to date, however, have relied mainly 
upon questionnaires to assess psychotic symptoms and have involved limited data on 
non-psychotic psychopathology. In addition, although research suggests that psychotic 
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symptoms are more common in younger compared to older children,2 there is a lack of 
information on whether there are differences in the clinical significance of psychotic 
symptoms across different stages of adolescence. In an attempt to improve our 
understanding of the clinical significance of psychotic symptoms in the general 
population, we examined data from four population studies, including two large 
population surveys and two in-depth clinical interview studies of psychotic symptoms. 
The aims of this work were (i) to investigate whether psychotic symptoms predicted non-
psychotic clinical diagnoses and, if so, which disorders (ii) to investigate whether 
psychotic symptoms predicted more clinically severe disorder, in terms of comorbid 
psychopathology (i.e., having more than 1 diagnosis) and (iii) to investigate whether the 
significance of psychotic symptoms varied as a function of age.  
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Survey studies 
Methods 
Study 1: Early adolescence survey study (Adolescent Brain Development study) 
Sixteen schools in Dublin, Ireland and surrounding areas, took part in this study. 
Participants were aged 11 to 13 years and were in 5th and 6th class in school, the two most 
senior classes in the Irish primary school system. This was an ‘opt in’ study, with written 
parental consent required for adolescents to take part. In total 2190 consent forms were 
distributed and 1131 (52%) parents gave signed consent for their child to complete the 
survey in school. A total of 88.9% of participants were Irish-born participants (compared 
to 90.3% of 0 to 14 year olds nationally in the 2006 national census). 
 
Survey Study 2: Mid adolescence survey study (Saving and Empowering Young 
Lives in Europe study)19 
Seventeen schools in Cork and Kerry, Ireland, took part in this study. Participants were 
aged 13 to 16 years and were attending second-level education. This was an ‘opt out’ 
study, with pupils allowed to take part if their parents did not return the consent form to 
specifically opt out. In total, 1602 consent forms were distributed and approximately 70% 
(n=1112) completed the survey in school. A total of 82.2% of participants were Irish 
born. 
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Exposure and Outcome measures 
Both studies had a common exposure and outcome measure. Using the Adolescent 
Psychotic Symptom Screener (APSS),20 we have previously shown that a question on 
auditory hallucinations (“Have you ever heard voices or sounds that no one else can 
hear?”) demonstrates very good positive and negative predictive validity not just for 
clinical interview-verifiable auditory hallucinations but for psychotic symptoms in 
general. This question was used in both survey studies to assess for psychotic symptoms 
(exposure measure). The Strengths and Difficulties Questionnaire (SDQ) was used as the 
measure of general psychopathology in both samples.21 The SDQ is a well-validated brief 
screening instrument, which asks about 25 attributes divided into subscales. The 
emotional disorders section assesses for anxiety, depressive and obsessive compulsive 
disorders, the conduct disorders section assesses for conduct and oppositional defiant 
disorders, and the hyperkinetic disorders section assesses for attention 
deficit/hyperactivity disorders. A ‘total difficulties’ score is also generated by summing 
the psychopathology subscales, which predicts the presence of any psychiatric disorder. 
The SDQ has been validated both in terms of its ability to distinguish between clinic and 
community samples22 and as a screening device to detect children with a mental health 
disorder.21 More recently, the SDQ has been shown not only to predict psychopathology 
at the same point in time but also to predict disorder status three years later.23 
 
Clinical Interview Studies 
Study 3: Early adolescence interview study (Adolescent Brain Development study)24 
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Participants in this clinical interview study were drawn from the larger survey study 
reported above (Study 1). Of the 1131 adolescents who took part in the survey study, 656 
(58%) indicated an interest in taking part in the interview study and a sample of 212 of 
these were brought for interview. A total of 88.9% of participants were Irish-born 
(compared to 90.3% of 0 – 14 year olds nationally). Adolescents who attended for 
interview were no more likely to have an abnormal or borderline-abnormal score on the 
SDQ21 (x2=1.22 (df=1) p=0.27) and did not differ significantly in their scores on the 
APSS20 compared to the non-interviewed sample (interviewed group mean=1.8 
(SE=0.12), non-interviewed group mean=1.9 (SE=0.19); t=0.26, df=1130, p=0.79). 
 
Study 4: Mid adolescence interview study (Challenging Times study)25, 26 
This study was established to investigate the prevalence of psychiatric disorders and 
suicidal behaviour among Irish adolescents aged 13 to 15 years. The study was carried 
out in the geographical catchment area of a Child and Adolescent Mental Health Team in 
North Dublin with a population of 137,000. The participating schools were selected using 
a stratified random sampling technique according to the approximate socioeconomic class 
of the school in order to approximate to the geographical area population. A total of 743 
pupils in eight mainstream schools were screened for psychiatric symptoms using the 
SDQ,21 and with the Children’s Depression Inventory,27 which assesses cognitive, 
affective and behavioural signs of depression. Written informed consent was obtained 
from the parent or guardian of participants.  One hundred and forty adolescents scored 
above threshold on these instruments, indicating high risk of having mental health 
problems, and all of these adolescents were invited to interview, of whom 117 (83.6%) 
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agreed to attend for full psychiatric interview. A comparison group of 173 adolescents, 
matched for gender and school were also invited to attend, of whom 94 (54%) agreed. A 
frequency weight was applied to participants in the CT study to account for enrichment 
for psychopathology so that reported rates represent the general population rather than a 
psychopathology-enriched sample. Data were not collected on participant nationalities. 
 
Exposure and Outcome Measures 
The interview instrument used was the Schedule for Affective Disorders and 
Schizophrenia for School-aged Children, Present and Lifetime versions (K-SADS-PL).28 
The K-SADS is a well-validated semi-structured research diagnostic interview for the 
assessment of all Axis-1 psychiatric disorders in children and adolescents. Children and 
parents were interviewed separately, both answering the same questions about the child. 
In the early adolescence study, interviews were conducted by two psychiatrists and four 
psychologists and in the mid adolescence study, interviews were conducted by one 
psychiatrist and two psychologists, all trained in the use of the K-SADS. Inter-rater 
reliability was >90% for both studies (kappa = 0.83 (Study 3) and 0.85 (Study 4)). The 
Psychosis section of the K-SADS was used to assess the participants’ psychotic 
symptoms (hallucinations and delusions). All interviewers recorded extensive notes of 
potential psychotic phenomena in this section of the interview and a clinical consensus 
meeting was held following the interviews to classify these phenomena as psychotic 
symptoms (or not), blind to diagnoses and all other information on the participants. The 
exposure measure was the presence or absence of psychotic symptoms and the outcome 
measure was a diagnosable lifetime affective, anxiety or behavioural disorder. 
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Statistical Analyses 
Survey Studies 
Statistical analyses were conducted using STATA version 11.0 for Windows. First, we 
used analysis of variance to test the association between auditory hallucinations and SDQ 
total difficulties score. Second, we divided the samples into quartiles based on their SDQ 
total difficulties scores and used logistic regression to test the odds of reporting psychotic 
symptoms in each quartile of (increasing) psychopathology. To test for a statistically 
significant increase (or decrease) in the prevalence of psychotic symptoms across the 
quartiles of SDQ-rated psychopathology, we used the STATA command nptrend, which 
is an extension of the Wilcoxon rank-sum test and performs a nonparametric test for trend 
across ordered groups. We also used logistic regression to compare the prevalence of 
auditory hallucinations among the 5% who scored highest on the SDQ total difficulties, 
which is often taken as a ‘severe’ psychopathology group, with the 5% who scored lowest 
on the SDQ total difficulties. Finally, we stratified by the number of SDQ-rated disorder 
domains (emotional, conduct and hyperkinetic disorders) and used logistic regression to 
determine whether psychotic symptoms predicted comorbidity across these domains and, 
therein, more severe psychopathology. 
 
Interview Studies 
Statistical analyses were conducted using STATA version 11.0 for Windows. Univariate 
and multivariate regression analyses were used to measure the relationship between 
psychopathology and psychotic symptoms. First, we report the prevalence of psychotic 
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symptoms in diagnosable affective, behavioural and anxiety disorders and report odds 
ratios and 95% confidence intervals. Second, we stratify by comorbidity/multiple 
pathology (i.e., having 2 or more Axis-1 diagnoses) in order to determine the prevalence 
of psychotic symptoms in increasingly severe (comorbid) disorders and report odds ratios 
and 95% confidence intervals for the association with psychotic symptoms. To test for a 
statistically significant increase (or decrease) in the prevalence of auditory hallucinations 
in line with the number of diagnosable psychiatric disorders, we used the STATA 
command nptrend, which is an extension of the Wilcoxon rank-sum test and performs a 
nonparametric test for trend across ordered groups. 
 
Ethical approval for Study 1 was received from the Beaumont Hospital Medical Ethics 
Committee; for Study 2 from the Clinical Research Ethics Committee of the Cork 
Teaching Hospitals; for Study 3 from the Beaumont Hospital Medical Ethics Committee; 
for Study 4 from the Mater Misericordiae University Hospital Medical Ethics Committee. 
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Results 
Results of Survey Studies 
Studies 1 and 2: Association between psychotic symptoms and psychopathology 
Psychotic symptoms were reported by 21% (n=239) of the early adolescence sample 
(Study 1) and 7% (n=77) of the mid adolescence sample (Study 2). Increasing ‘total 
difficulties’ scores on the SDQ were associated with increasing odds of reporting 
psychotic symptoms (Study 1: F=94.72, p<0.001; Study 2: F=104.81, p<0.001). 
Adolescents who scored within the top quartile for SDQ-measured psychopathology in 
the early adolescence study were 6.5 times more likely to report psychotic symptoms 
compared to those in the lowest quartile (test for trend, Z = 8.60, p<0.001). Adolescents 
who scored within the top quartile for SDQ-measured psychopathology in the mid 
adolescence study were nearly 16 times more likely to report psychotic symptoms 
compared to those in the lowest quartile (test for trend, Z = 7.32, p<0.001) (see Table 1). 
In fact, in Study 1, among adolescents with the top 5% most severe SDQ total difficulties 
scores, 48.1% reported psychotic symptoms, in contrast to just 2.9% of adolescents with 
the lowest 5% SDQ total difficulties score (OR=31.10, CI95=6.91-140.02, p<0.001). In 
Study 2, among adolescents with the top 5% most severe ‘total difficulties’ scores, 35% 
reported psychotic symptoms, in contrast to just 1.4% of adolescents with the lowest 5% 
‘total difficulties’ scores (OR=38.78, CI95=4.95-304.02, p<0.001). Psychotic symptoms 
were not confined to any one disorder – rather they were reported at an increased 
prevalence across each of the SDQ-rated emotional, conduct and hyperkinetic disorders 
(see Table 2).  
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Comparisons between Study 1 and Study 2: 
The risk for psychopathology in adolescents with psychotic symptoms varied as a 
function of age, with participants less likely to endorse the auditory hallucinations 
question as age increased. However, psychotic symptoms became more closely 
associated with psychopathology as age increased, in that 49% of the early adolescent 
sample who endorsed the auditory hallucinations question scored in the clinical 
psychopathology range on at least one SDQ-rated disorder domain compared to 65% of 
the mid adolescence sample (see Figure 1). 
 
Multiple psychopathology in Study 1 and Study 2: 
In order to investigate whether psychotic symptoms were more prevalent in adolescents 
with more severe psychopathology, we calculated the prevalence of psychotic symptoms 
among adolescents who scored positive for psychopathology on 1, 2 or all 3 of the 
disorder domains compared to adolescents with no disorder. In the early adolescence 
sample (Study 1), 15% of participants with no SDQ-rated disorders reported psychotic 
symptoms, compared to 33% of adolescents who were abnormal on 1 SDQ disorder 
domain (OR=2.71, CI95=1.85-3.98, p<0.001), 43% of adolescents who were abnormal 
on 2 SDQ disorder domains (OR=4.85, CI95=2.69-8.74, p<0.001) and 54% of 
adolescents who were abnormal on all 3 SDQ disorder domains (OR=8.59, CI95=2.00-
36.92, p<0.001) (test for trend: Z = 7.83, p<0.001). Among the mid adolescence sample 
(Study 2), the prevalence of psychotic symptoms among those who were not abnormal on 
any of the 3 SDQ disorder domains was less than 4%, but for psychopathology in 1 
domain the prevalence of hallucinations was 11% (OR=3.33, CI95=1.91-5.80, p<0.001), 
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for psychopathology in 2 domains the prevalence of hallucinations was 24% (OR=8.00, 
CI95=4.02-15.92, p<0.001), and for psychopathology in all 3 domains the prevalence of 
hallucinations was 33% (OR=12.96, CI95=4.53-37.08, p<0.001) (test for trend, Z = 7.33, 
p<0.001). 
 
Results of Interview Studies 
Thirty one percent of the early adolescence interview study sample (Study 3) had a 
lifetime diagnosable affective, anxiety or behavioural disorder. The lifetime disorders 
included depressive disorders, including major depressive disorder (MDD) and 
adjustment disorder with depressed mood (15%); behavioural disorders, including 
attention deficit/hyperactivity disorder (ADHD), oppositional defiant disorder and 
conduct disorder (9%); and anxiety disorders, including, generalized anxiety disorder, 
social phobia, separation anxiety disorder and obsessive compulsive disorder (14%). 
 
Thirty four percent of the mid adolescent interview study sample (Study 4) had a lifetime 
diagnosable affective, anxiety or behavioural disorder. The lifetime disorders included 
depressive disorders, including MDD and adjustment disorder with depressed mood 
(18%); behavioural disorders, including ADHD, oppositional defiant disorder and 
conduct disorder (9%); and anxiety disorders, including generalized anxiety disorder, 
social phobia, separation anxiety disorder, obsessive compulsive disorder and panic 
disorder (11%). 
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Study 3: Psychotic symptoms and association with psychopathology – early 
adolescence 
In the early adolescence sample, 22.6% (n=53) reported psychotic symptoms, primarily 
auditory hallucinations (>90%). The prevalence of psychotic symptoms was higher 
among males (χ2=7.03, p<0.01). While participants were asked about lifetime psychotic 
symptoms, in almost all cases adolescents who reported psychotic symptoms had 
experienced these symptoms within the past year – only 3 participants from the entire 
sample who reported lifetime psychotic symptoms did not report experiencing these 
symptoms within the past year, indicating that a report of lifetime symptoms in reality 
almost always indicates recent (within previous 12 months) symptoms. Of all adolescents 
who reported psychotic symptoms, 57% had a lifetime diagnosable Axis-1 disorder 
(OR=3.73, CI95=1.97-7.07, p<0.001) and 30.2% had a current diagnosable Axis-1 
disorder (OR=3.46, CI95=1.64-7.31, p<0.01). Adolescents with a lifetime diagnosable 
affective disorder were 5-times more likely to report psychotic symptoms compared to 
the rest of the sample, while adolescents with a lifetime diagnosable behavioural disorder 
were 3-times more likely to report psychotic symptoms (see Table 3) 
 
Study 4: Psychotic symptoms and association with psychopathology – mid-
adolescence 
In the mid-adolescence sample, 7% of participants reported psychotic symptoms, 
primarily auditory hallucinations (>90%). There was a trend for psychotic symptoms to 
be more prevalent among males (χ2=3.62, p=0.057). Of all adolescents who reported 
psychotic symptoms, 79% had a lifetime diagnosable Axis-1 disorder (OR=11.94, 
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CI95=3.14-45.41, p<0.01) and 43% had a current diagnosable Axis-1 disorder (OR=4.27, 
CI95=1.38-13.21, p=0.01). Adolescents with a lifetime diagnosable affective disorder 
were more than 10-times more likely to report psychotic symptoms compared to the rest 
of the sample, while adolescents with a lifetime diagnosable behavioural disorder were 5-
times more likely to report psychotic symptoms (see Table 3).  
 
Interview Studies: Multiple psychopathology 
Multiple psychopathology (i.e., the presence of more than 1 diagnosable disorder) was 
present in 15% (n=35) of the early adolescence sample (Study 3). We observed a dose-
response relationship between the number of diagnoses the adolescent had and their risk 
of reporting psychotic symptoms (see Table 4 and Figure 1). Multiple psychopathology 
was present in 10% (n=21) of the mid-adolescence sample (Study 4). We also observed a 
dose-response relationship between the number of diagnoses the adolescent had and their 
risk of reporting psychotic symptoms in this sample (see Table 4 and Figure 1). 
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Discussion 
Using two large population-based survey studies and two in-depth clinical interview 
studies, we have shown a number of important findings. (i) Psychotic symptoms are 
prevalent in a wide range of non-psychotic psychopathologies. (ii) While psychotic 
symptoms are not pathognomonic of illness, the majority of young people in the 
community who report psychotic symptoms do have a diagnosable psychiatric disorder. 
(iii) Psychotic symptoms index particularly high risk for multiple pathology, that is 
having more than 1 DSM diagnosis. (iv) Psychotic symptoms are reported more 
commonly in early compared to middle adolescence. (v) Psychotic symptoms become 
increasingly predictive of diagnosable psychopathology with increasing age.  
 
While some research has shown that the majority of psychotic symptoms in childhood are 
transient, with symptoms that persist over time thought to be of more clinical 
significance,29 in the current study the majority of adolescents who reported psychotic 
symptoms had at least one diagnosable psychiatric disorder, regardless of the issue of 
psychotic symptom persistence. Increased risk for psychopathology was not related to a 
particular diagnosis or even one group of disorders; rather, a variety of Axis-1 disorders 
were associated with psychotic symptoms. Interestingly, however, psychotic symptoms 
demonstrated a particularly strong relationship with more severe psychopathology, with 
prevalence of psychotic symptoms increasing in a dose-response fashion with the number 
of diagnosable disorders. In Study 4, for example, 40% of adolescents with three or more 
comorbid disorders reported psychotic symptoms, compared to just 8% of adolescents 
with only one disorder (see Table 3). 
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Psychotic symptoms were more common in early adolescence in both the surveyed and 
interviewed samples (21% to 23%) compared to middle adolescence (7% in both the 
surveyed and interviewed samples). This is in line with meta-analytic findings of a 
decline in prevalence of psychotic symptoms from childhood into adolescence.2 
However, associations between psychotic symptoms and diagnosable disorder were 
stronger in the older, compared to the younger, samples. While 57% of the early 
adolescence sample who reported psychotic symptoms had a diagnosable psychiatric 
disorder, nearly 80% of the mid adolescence sample who reported psychotic symptoms 
had at least 1 diagnosable disorder. In a study of younger children, aged 7 to 8, Bartels-
Velthuis et al. found that auditory hallucinations were associated with only a minor 
increase in risk for parent-reported behavioural and emotional symptoms30 but that at age 
12 to 13 years psychotic symptoms predicted an approximately 3- to 5-fold increased risk 
of scoring in the clinical range of the Child Behaviour Checklist.18 Hallucinatory and 
delusional experiences, then, may fall within the normal spectrum of experience in 
childhood but might be expected to discontinue in the course of development. Psychotic 
symptoms in adolescence, the current findings suggest, become increasingly associated 
with psychopathology – in particular with severe, multiple diagnoses (see Figure 1). 
 
There are a number of possible explanations as to how psychotic symptoms act as a 
marker for a wide range of psychopathology. One possibility is that the same risk factors 
may predispose to both psychotic symptoms and psychiatric illness. In fact, Breetvelt et 
al. have recently demonstrated that many risk factors that have typically been considered 
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risk factors for psychosis are risk factors for a wider range of (non-psychotic) 
psychopathology.31 It is also possible that psychological distress caused by psychotic 
symptoms contributes to, for example, depressive thoughts or behavioural symptoms. It 
may also be the case, however, that psychotic symptoms do not contribute to 
psychopathology per se but, rather, emerge in vulnerable individuals who experience 
non-psychotic psychopathology and therein act as a marker, rather than an aetiological 
factor, for non-psychotic psychopathology. From a biological perspective, Alemany et al. 
have recently published the first study documenting a molecular genetic association, 
showing an interaction between the BDNF val-met polymorphism and childhood trauma 
in increasing risk for psychotic symptoms.32 The limited structural and functional 
magnetic resonance imaging (MRI) research on psychotic symptoms to date suggests that 
adolescents with psychotic symptoms exhibit a profile of subtle neurodevelopmental 
differences that shares features with a number of psychiatric disorders.33 A recent meta-
analysis of brain volume abnormalities in major depressive disorder, for example, showed 
that the greatest changes occur in two regions important in emotion processing and stress 
regulation – the cingulum and orbitofrontal cortex,34 both of which we have recently 
shown to be abnormal in adolescents with psychotic symptoms.33 Using functional MRI 
and digital tractography, we have demonstrated reduced activity within the right frontal 
and bilateral temporal cortices during response inhibition tasks and overall reduced 
integrity of fronto-temporal pathways in adolescents with psychotic symptoms,33 
supporting a profile of a relative disinhibition/pro-impulsivity phenotype. These 
neurobiological findings mirror our clinical findings of increased affective and 
behavioural disorders. From a psychological perspective, psychotic symptoms in young 
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people have been linked to poorer theory of mind and an externalised locus of control,35, 
36 both of which have been shown to predict poorer mental health outcomes.37, 38 
 
The relevance of the current findings extends beyond adolescent mental health; the 
finding that psychotic symptoms are highly prevalent in a range of (non-psychotic) 
disorders raises questions about traditional diagnostic boundaries. While psychosis has 
conventionally been considered as separate to ‘neurotic’ disorders, a number of 
researchers have questioned the independence of the psychoses and non-psychotic 
psychopathology.39-41 The findings of the current work, which show that psychotic 
symptoms are prevalent in a wide variety of non-psychotic disorders, suggest that 
divisions between the neuroses and psychoses are not clear cut. 
 
There are a number of strengths to the current paper, most notably the use of four studies, 
each of which shows the same pattern of results. While the larger survey studies allowed 
us to test for relationships between psychotic symptoms and psychopathology in terms of 
a symptomatic continuum, the downside of this approach is that clinical implications, in 
the absence of actual diagnoses, can be hard to draw. However, the inclusion of two 
clinical interview studies allows us to draw clear clinical implications by exploring the 
relationship between psychotic symptoms and actual psychiatric diagnoses. The use of 
multiple studies also allowed us to examine the relationship between psychotic symptoms 
and psychopathology from early through middle adolescence. In addition, the use of 
community samples is particularly valuable because findings are generalisable to the 
population. A limitation is that the issue of temporality cannot be resolved in the current 
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study i.e., which came first: psychotic symptoms or psychopathology, or, indeed, did both 
arise together. However, this does not detract from the clinical utility of understanding 
the contemporaneous relationship between psychotic symptoms and non-psychotic 
psychopathology. Subgroup analyses within studies means that there are small groups 
and confidence intervals, as a result, are wide in some cases. However, the same pattern 
of results was found across all four studies showing that the findings are robust. 
 
Conclusion  
Hallucinations and delusions, while classically known as symptoms of psychosis, are 
common in a wide range of non-psychotic psychiatric disorders in young people. These 
symptoms become increasingly associated with diagnosable psychopathology with age. 
Psychotic symptoms demonstrated a particularly strong relationship with more severe 
psychopathology, indexing high risk for multiple disorders (i.e., the presence of 2 or more 
co-occurring diagnoses). The immediate clinical implications of these findings are that (i) 
psychotic symptoms, which are to a large extent seen as an ‘adult psychiatry’ issue, are in 
fact very prevalent in childhood and adolescence and should be carefully assessed in 
child and adolescent psychiatric clinics, and (ii) when psychotic symptoms are present, 
they index risk for severe psychopathology, in terms of the patient having more than one 
diagnosable disorder and, following from this, the potential importance of multiple 
therapeutic targets or approaches. For researchers, these findings highlight psychotic 
symptoms as a complex novel aspect in the study of the aetiology of severe mental 
illness, of which schizophrenia is only one. Research has only recently begun on neuro-
genetics, imaging, electrophysiology and cognition among individuals with psychotic 
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symptoms.32, 33, 42-44 Much more work will be necessary to explore the role of psychotic 
symptoms – symptoms which, to date, have been largely considered features of psychotic 
illness – in the aetiology of a broad range of non-psychotic psychiatric disorders. 
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Table 1: Odds of experiencing psychotic symptoms according to SDQ psychopathology scores in quartiles (a) unadjusted and (b) 
adjusted for sex in Study 1 (early adolescence survey study) and Study 2 (mid adolescence survey study). 
Quartile N % with 
psychotic 
symptoms 
Early adolescence survey study  
OR (CI95) 
(a)                           (b) 
N % with psychotic 
symptoms 
Mid adolescence survey study  
OR (CI95) 
(a)                                (b) 
1 313 7.7% 1 1 278 1.4% 1 1 
2 322 18% 2.31 (1.42-3.76) 1.91 (1.10-3.32) 234 3.4% 2.40 (0.71-8.07) 2.35 (0.69-7.90) 
3 221 22.2% 3.00 (1.81-4.97) 2.59 (1.45-4.60) 250 5.7% 4.07 (1.32-12.55) 4.08 (1.32-12.59) 
4 276 38.2% 6.50 (4.09-10.33) 5.50 (3.25-9.30) 235 19% 15.80 (5.58-44.71) 15.82 (5.57-44.94) 
Test for trend across quartiles Z=8.60, p<0.001  Z=7.32, p<0.001 
SDQ, Strengths and Difficulties Questionnaire 
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Table 2: Odds of experiencing psychotic symptoms among adolescents with SDQ-rated emotional, hyperkinetic and conduct disorders 
(a) unadjusted and (b) adjusted for sex in Study 1 (early adolescence survey study) and Study 2 (mid adolescence survey study). 
 % with 
psychotic 
symptoms 
Early adolescence survey study  
OR (CI95) 
(a)                                       (b) 
% with 
psychotic 
symptoms 
Mid adolescence survey study  
OR (CI95) 
(a)                                    (b) 
Emotional 
disorders  
44% 3.44 (2.33-5.10) 2.98 (1.89-4.69) 22% 4.79 (2.78-8.28) 5.19 (2.97-9.06) 
Hyperkinetic 
disorders  
35% 2.34 (1.62-3.37) 2.74 (1.80-4.18) 15% 3.06 (1.86-5.04) 3.00 (1.81-4.98) 
Conduct 
disorders  
36% 2.38 (1.63-3.48) 2.91 (1.85-4.58) 20% 4.60 (2.75-7.71) 4.68 (2.77-7.93) 
SDQ, Strengths and Difficulties Questionnaire 
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Table 3: Odds of experiencing psychotic symptoms among adolescents with lifetime DSM IV Axis-1 diagnoses diagnosed by clinical 
interview (a) unadjusted and (b) adjusted for sex in Study 3 (early adolescence interview study) and Study 4 (mid adolescence 
interview study) 
Diagnosis % with psychotic 
symptoms 
Early adolescence interview study OR 
(CI95)  
(a)                                (b) 
 
% with 
psychotic 
symptoms 
Mid adolescence interview study OR 
(CI95)  
(a)                           (b) 
 
Any lifetime Axis-1 
disorder  
40% 3.73 (1.97-7.07) 3.57 (1.87-6.84) 19% 11.15 (2.99-41.65) 11.94 (3.14-45.41) 
Affective disorders 
 
51% 4.93 (2.31-10.51) 5.08 (2.33-11.07) 24% 10.67 (3.33-34.19) 12.33 (3.69-41.19) 
Behavioural disorders 
 
50% 3.95 (1.55-10.10) 3.23 (1.24-8.43) 22% 5.14 (1.43-18.51) 4.55 (1.23-16.75) 
Anxiety disorders 
 
23% 0.99 (0.48-2.06) 1.01 (0.48-2.12) 9% 1.45 (0.30-6.95) 1.67 (0.34-8.22) 
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Table 4: Odds of experiencing psychotic symptoms in adolescents with one, two or three or more comorbid DSM-IV Axis-1 disorders 
diagnosed by clinical interview, (a) unadjusted and (b) adjusted for sex, in Study 3 (early adolescence interview study) and Study 4 
(mid adolescence interview study). 
Diagnosis % with psychotic 
symptoms 
Early adolescence interview study 
OR (CI95)  
(a)                        (b) 
 
% with 
psychotic 
symptoms 
Mid adolescence interview study  
OR (CI95)  
(a)                          (b) 
 
One disorder only 
 
29% 2.25 (1.06-4.75) 2.27 (1.06-4.87) 8% 3.86 (0.83-17.88) 4.12 (0.88-19.38) 
Two disorders 
only 
38% 3.23 (1.27-8.27) 3.18 (1.22-8.29) 31% 20.15 (4.24-95.59) 18.33 (3.77-89.15) 
Three or more 
disorders 
55% 6.47 (1.82-22.98) 6.31 (1.73-23.05) 40% 29.56 (3.53-247.17) 36.18 (3.94-332.06) 
Test for trend Z = 3.67, p < 0.001  Z = 4.29, p < 0.001 
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Figure 1: Prevalence of psychotic symptoms by comorbid diagnoses in the early adolescence survey sample (study 1: green line), early 
adolescence interview sample (study 3: blue line), mid adolescence survey sample (study 2: black line) and mid adolescence interview 
sample (study 4: red line) 
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